Longeveron (LGVN) Receivables (2020 - 2026)
Longeveron (LGVN) posted quarterly Receivables of $68000.0 for Q1 2026, up 134.48% year-over-year from $29000.0 in Q1 2025, and down 34.62% quarter-over-quarter from $104000.0 in Q4 2025.
Longeveron (LGVN) Receivables (2020 - 2026) Analysis & Trends
Longeveron's Receivables history runs 7 years deep, the most recent figure standing at $68000.0 for Q1 2026.
- In Q1 2026, Receivables rose 134.48% year-over-year to $68000.0; the TTM figure through Mar 2026 stood at $68000.0 (up 134.48% YoY), while the FY2025 annual figure was $104000.0, up 23.81% from the prior year.
- Receivables for Q1 2026 stood at $68000.0, down from $104000.0 in the prior quarter.
- The five-year high for Receivables was $380000.0 in Q3 2024, with the low at $29000.0 in Q1 2025.
- The 5-year median for Receivables is $96000.0 (2022), against an average of $127647.1.
- The sharpest annual moves came in 2022 and 2025: Receivables surged 296.36% in 2022, then tumbled 86.32% in 2025.
- Longeveron's Receivables stood at $218000.0 in 2022, then slumped by 49.08% to $111000.0 in 2023, then dropped by 24.32% to $84000.0 in 2024, then gained by 23.81% to $104000.0 in 2025, then tumbled by 34.62% to $68000.0 in 2026.
- Business Quant data shows LGVN's Receivables at $68000.0 in Q1 2026, $104000.0 in Q4 2025, and $52000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Longeveron | 26.51 Mn | 16.41 Mn | 182,000.00 | 65,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 84,000.00 |
| Sep 30, 2024 | 380,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 178,000.00 |
| Dec 31, 2023 | 111,000.00 |
| Sep 30, 2023 | 96,000.00 |
| Jun 30, 2023 | 96,000.00 |
| Mar 31, 2023 | 96,000.00 |
| Dec 31, 2022 | 218,000.00 |
| Sep 30, 2022 | 177,000.00 |
| Jun 30, 2022 | 136,000.00 |
| Mar 31, 2022 | 96,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Sep 30, 2021 | 171,000.00 |